Alper Sonmez1, Cem Haymana2, Fahri Bayram3, Serpil Salman4, Oguzhan Sitki Dizdar5, Eren Gurkan6, Ayse Kargili Carlıoglu7, Cem Barcin8, Tevfik Sabuncu9, Ilhan Satman10. 1. Health Sciences University, Gulhane Faculty of Medicine, Department of Endocrinology and Metabolism, Ankara, Turkey. 2. Gulhane Training and Research Hospital, Department of Endocrinology and Metabolism, Ankara, Turkey. Electronic address: cemhaymana@hotmail.com. 3. Erciyes University, Faculty of Medicine, Department of Endocrinology and Metabolism, Kayseri, Turkey. 4. Istinye University, Faculty of Medicine, Department of Endocrinology and Metabolism, Istanbul, Turkey. 5. Kayseri Training and Research Hospital, Department of Endocrinology and Metabolism, Kayseri, Turkey. 6. Mustafa Kemal University, Faculty of Medicine, Department of Endocrinology and Metabolism, Hatay, Turkey. 7. Erzurum Training and Research Hospital, Department of Endocrinology and Metabolism, Erzurum, Turkey. 8. Health Sciences University, Gulhane Faculty of Medicine, Department of Cardiology, Ankara, Turkey. 9. Harran University, Faculty of Medicine, Sanliurfa, Turkey. 10. Istanbul University, Faculty of Medicine, Istanbul, Turkey.
Abstract
AIMS: Turkey has the highest prevalence of diabetes in Europe. It is therefore essential to know the overall cardiovascular risk and reveal the predictors of metabolic control in Turkish adults with diabetes mellitus. METHODS: A nationwide, multicenter survey consecutively enrolled patients who were under follow up for at least a year. Optimal control was defined as HbA1c < 7%, home arterial blood pressure (ABP) < 135/85 mmHg, or LDL-C < 100 mg/dL. Achieving all parameters indicated triple metabolic control. RESULTS: HbA1c levels of patients (n = 5211) were 8.6 ± 1.9% (71 ± 22 mmol/mol) and 7.7 ± 1.7% (61 ± 19 mmol/mol), in Type 1 and Type 2 diabetes, respectively. Glycemic control was achieved in 15.3% and 40.2%, and triple metabolic control was achieved in 5.5% and 10.1%, respectively. Only 1.5% of patients met all the criteria of being non-obese, non-smoker, exercising, and under triple metabolic control. Low education level was a significant predictor of poor glycemic control in both groups. CONCLUSIONS: Few patients with Type 2, and even fewer with Type 1 diabetes have optimal metabolic control in Turkey. TEMD study will provide evidence-based information to policy makers to focus more on the quality and sustainability of diabetes care in order to reduce the national burden of the disease.
AIMS: Turkey has the highest prevalence of diabetes in Europe. It is therefore essential to know the overall cardiovascular risk and reveal the predictors of metabolic control in Turkish adults with diabetes mellitus. METHODS: A nationwide, multicenter survey consecutively enrolled patients who were under follow up for at least a year. Optimal control was defined as HbA1c < 7%, home arterial blood pressure (ABP) < 135/85 mmHg, or LDL-C < 100 mg/dL. Achieving all parameters indicated triple metabolic control. RESULTS: HbA1c levels of patients (n = 5211) were 8.6 ± 1.9% (71 ± 22 mmol/mol) and 7.7 ± 1.7% (61 ± 19 mmol/mol), in Type 1 and Type 2 diabetes, respectively. Glycemic control was achieved in 15.3% and 40.2%, and triple metabolic control was achieved in 5.5% and 10.1%, respectively. Only 1.5% of patients met all the criteria of being non-obese, non-smoker, exercising, and under triple metabolic control. Low education level was a significant predictor of poor glycemic control in both groups. CONCLUSIONS: Few patients with Type 2, and even fewer with Type 1 diabetes have optimal metabolic control in Turkey. TEMD study will provide evidence-based information to policy makers to focus more on the quality and sustainability of diabetes care in order to reduce the national burden of the disease.
Authors: Xiu-Ya Xing; Xin-Yi Wang; Xi Fang; Jing-Qiao Xu; Ye-Ji Chen; Wei Xu; Hua-Dong Wang; Zhi-Rong Liu; Sha-Sha Tao Journal: Front Public Health Date: 2022-10-04
Authors: Fahri Bayram; Alper Sonmez; Cem Haymana; Tevfik Sabuncu; Oguzhan Sitki Dizdar; Eren Gurkan; Ayse Kargili Carlioglu; Kemal Agbaht; Didem Ozdemir; Ibrahim Demirci; Cem Barcin; Serpil Salman; Tamer Tetiker; Mustafa Kemal Balci; Nur Kebapci; Canan Ersoy; Volkan Yumuk; Peter P Toth; Ilhan Satman Journal: Lipids Health Dis Date: 2020-11-11 Impact factor: 3.876